68 results
8-K
EX-1.1
CPRX
Catalyst Pharmaceuticals Inc
5 Jan 24
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
5:23pm
is in compliance with all applicable corporate governance requirements, if any, set forth in the rules of the Nasdaq Capital Market
424B5
CPRX
Catalyst Pharmaceuticals Inc
5 Jan 24
Prospectus supplement for primary offering
5:15pm
.
Provisions of the Certificate and Bylaws
A number of provisions of our certificate of incorporation and bylaws concern matters of corporate governance
424B5
CPRX
Catalyst Pharmaceuticals Inc
4 Jan 24
Prospectus supplement for primary offering
6:24pm
.
Provisions of the Certificate and Bylaws
A number of provisions of our certificate of incorporation and bylaws concern matters of corporate governance
S-3ASR
CPRX
Catalyst Pharmaceuticals Inc
8 Sep 23
Automatic shelf registration
4:31pm
of incorporation and bylaws concern matters of corporate governance and the rights of stockholders. Certain of these provisions, as well as the ability of our
8-K
lxbtm1rekka7
31 Mar 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-2.1
g3zv4e9 dhu87n8g
22 Dec 22
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
4:31pm
8-K
n9g977k8w7mnwzs 0k4s
11 Sep 20
Departure of Directors or Certain Officers
5:00pm
8-K
t9sxkgmy3mrtxcpn
21 Aug 20
Departure of Directors or Certain Officers
5:00pm
424B3
rgp96rs4gt6m38or7rh5
31 Jul 20
Prospectus supplement
5:01pm